Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SR 1802Session 2026

Tardive Dyskinesia Awareness Week

S 1802 Filed

Florida Senate - 2026 (NP) SR 1802 By Senator Rodriguez 40-02159-26 20261802__ 1 Senate Resolution 2 A resolution recognizing the week of May 3, 2026 as 3 “Tardive Dyskinesia Awareness Week” in Florida and 4 expressing the Senate’s support of efforts to raise 5 awareness about the causes, symptoms, and importance 6 of routine screening for tardive dyskinesia. 7 8 WHEREAS, such serious mental illnesses as bipolar disorder, 9 major depressive disorder, and schizophrenia often require 10 treatment with antipsychotic medications for effective 11 management, and antipsychotic prescribing rates continue to 12 rise, and 13 WHEREAS, while prolonged antipsychotic use may be essential 14 for the treatment of certain conditions, it is associated with 15 tardive dyskinesia (TD), a condition marked by uncontrollable, 16 abnormal, and repetitive movements of the face, torso, limbs, or 17 extremities, and 18 WHEREAS, people at higher risk of TD include those older 19 than 55 years of age; black individuals; women; individuals with 20 mood or substance use disorders, intellectual disabilities, or 21 central nervous system injuries; and those with high cumulative 22 antipsychotic exposure, and 23 WHEREAS, approximately 60 percent of the estimated 800,000 24 U.S. adults living with TD remain undiagnosed, and even mild TD 25 symptoms can be stigmatizing and impair physical, social, and 26 emotional well-being, underscoring the urgency of early 27 screening, detection, and intervention, and 28 WHEREAS, the American Psychiatric Association recommends 29 routine TD screening in its clinical guidelines for 30 antipsychotic treatment, and individuals treated with 31 antipsychotics or experiencing abnormal movements should consult 32 their health care providers to assess TD risk, receive TD 33 screenings, and determine appropriate treatment, and 34 WHEREAS, treatments approved by the United States Food and 35 Drug Administration for TD can provide options for symptom 36 management and improved quality of life for many individuals 37 living with TD, and 38 WHEREAS, education and awareness for health care providers, 39 patients, and care partners can help ensure patients prescribed 40 antipsychotics receive care and support that aligns with 41 clinical best practices, including regular TD screenings, NOW, 42 THEREFORE, 43 44 Be It Resolved by the Senate of the State of Florida: 45 46 That the week of May 3, 2026 is recognized as “Tardive 47 Dyskinesia Awareness Week” in Florida, and that the Senate 48 expresses its support of efforts to raise awareness about the 49 causes, symptoms, and importance of routine screening for 50 tardive dyskinesia.

Official text from the Florida Legislature. Formatting has been adapted for reading on Ratifi.